ArticleThe oncologist2025

Tumor-infiltrating lymphocytes as predictive biomarkers in neoadjuvant treatment of HER2-positive breast cancer.

Oğuzcan Kınıkoğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.